SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biotech success, 2002
An SI Board Since January 2002
Posts SubjectMarks Bans
117 19 0
Emcee:  Miljenko Zuanic Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
92Lilly and Amylin To Collaborate on Potential Breakthrough Diabetes Treatment Fnigel bates-9/20/2002
91SOUTH SAN FRANCISCO and BERKELEY, Calif.--(BUSINESS WIRE)--Sept. 17, 2002--Genennigel bates-9/17/2002
90Roche and Trimeris Submit New Drug Application for FUZEON(TM), First Fusion Inhinigel bates-9/17/2002
89Good news from memantine for FRX and NTII: <i>Press Release Source: ForesBiomaven-9/10/2002
88Not that market care... Press Release Source: Versicor Inc. Versicor AnnounceMiljenko Zuanic-9/5/2002
87Press Release Source: InterMune, Inc. InterMune Announces Phase III Data DemonMiljenko Zuanic-8/28/2002
86FOR IMMEDIATE RELEASE P02-25 August 12, 2002 sim1-8/12/2002
85maybe two....... Tuesday July 30, 6:24 pm Eastern Time Press Release SOURCE: Trscaram(o)uche-7/30/2002
84snake bit company gets a break....... Tuesday July 30, 6:27 pm Eastern Time Prescaram(o)uche-7/30/2002
83CVT-3146 Phase II Trial Results Support CV Therapeutics' Plan to Advance IntElmer-7/29/2002
82Thursday July 11, 1:00 am Eastern Time Press Release SOURCE: Serono S.A. Serono Miljenko Zuanic-7/11/2002
81Friday July 5, 9:51 am Eastern Time AstraZeneca Gets First Market Approval for Miljenko Zuanic-7/5/2002
80FDA approves Medtronic bone-growth product aknahow-7/2/2002
79Neurocrine Biosciences Announces Positive Phase II Efficacy and Safety Results WElmer-6/24/2002
78Stressgen and Roche [Heat shock protein] Message 17642399michael_f_murphy-6/24/2002
77Tuesday June 18, 7:31 am Eastern Time Press Release SOURCE: Inspire PharmaceuticMiljenko Zuanic-6/18/2002
76Continued Impressive Interim Results From Aphton's Phase II Clinical Trial Wnigel bates-6/12/2002
75Thursday May 23, 5:43 pm Eastern Time Press Release SOURCE: Biogen, Inc. FDA AMiljenko Zuanic-5/24/2002
74Someone noticed it... Aphton Collaborators Receive Blue Ribbon Poster of Distinnigel bates-5/23/2002
73GSK has no time to spare! Wednesday May 22, 1:17 am Eastern Time Glaxo, U.S. FMiljenko Zuanic-5/22/2002
7293% viral response! Monday May 20, 8:43 am Eastern Time Reuters Company News RoMiljenko Zuanic-5/21/2002
71Maybe this will growth further. Monday May 20, 8:44 am Eastern Time Press ReleaMiljenko Zuanic-5/21/2002
70What will be schedule and dose for combination therapy, most likely in PIII triaMiljenko Zuanic-5/19/2002
69This are encouraging results for GVAX PC vaccine. However (and for sake of the mMiljenko Zuanic-5/19/2002
68thanks very much. Please do keep us informed. It's all very much appreciatedEepOpp-5/17/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News